Tesaro names chief commercial officer
This article was originally published in Scrip
Executive Summary
Waltham, Massachusetts-based Tesaro, an oncology-focused biopharmaceutical company, has appointed Grant C Bogle to the newly created position of senior vice-president and chief commercial officer. In this role, Mr Bogle will report to Lonnie Moulder, CEO of Tesaro, and will lead the company's marketing, sales, and market access teams. Most recently he was senior vice-president, pharmaceutical and biotech solutions at McKesson Specialty Health, where he led the informatics, health economics and outcomes research, reimbursement access and safety services, and US Oncology Clinical Research business units.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.